However, no disease-associated human SCAMP5 point mutations were reported until 2020, when Hubert et al. reported two unrelated patients with an identical heterozygous SCAMP5 variant (p. Gly180Trp) who had ASD, intellectual disability, and seizures (Hubert et al., 2020). The gene discussed is SCAMP5; the disease is Intellectual disability.